Additionally, studies in rats have found that Nesfatin-1 can inhibit cell apoptosis induced by IL-1β inflammation and promote angiogenesis by inhibiting neutrophil recruitment, cell apoptosis, and activating VEGF, mechanisms that can indirectly promote tumor bone metastasis (177, 178). Here, NUCB2 is linked to neoplasm.